Avatrombopag Usage in NSAA
- First Posted Date
- 2021-01-28
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04728789
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Application of Visual Laryngeal Mask Airway Combined With Endotracheal Intubation in General Anesthesia
Not Applicable
- Conditions
- General AnesthesiaLaryngeal MaskEndotracheal IntubationSurgery
- Interventions
- Device: visual laryngeal mask
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2021-01-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT04719767
Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT04689893
- Locations
- 🇨🇳
Peking union medical college hospital, Beijing, Dongcheng, China
Effect of Dietary Fiber on Metabolism, Inflammation and Nutritional Status in Patients With Chronic Diseases
Not Applicable
- Conditions
- Chronic DiseaseDietary Fiber
- Interventions
- Dietary Supplement: Nutrition ManagementDietary Supplement: Nutrition Management and Dietary Fiber
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT04690075
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Wearable Electrocardiogram Monitoring Device and Smartphone Application in Perioperative Pain Management
Recruiting
- Conditions
- Pain, Postoperative
- First Posted Date
- 2020-12-28
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 91
- Registration Number
- NCT04686526
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients
Not Applicable
- Conditions
- Cholecystitis/CholelithiasisPolyp GallbladderCholecystitis; Gallstone
- Interventions
- Other: Standard Pressure Laparoscopic CholecystectomyOther: Low Pressure Laparoscopic Cholecystectomy
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-23
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT04670952
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
A Real-world Study of Durvalumab for Lung Cancer in China
Recruiting
- Conditions
- Small-Cell Lung CancerNon Small Cell Lung Cancer Stage III
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04672759
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC
- Conditions
- Extensive-stage Small Cell Lung Cancer
- Interventions
- Drug: Chemotherapy Drugs, Cancer
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2020-12-11
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT04663438
- Locations
- 🇨🇳
Peking union medical college hospital，, Beijing, Beijing, China
Routine Staple Line Reinforcement for Minimally Invasive Distal Pancreatectomy
Not Applicable
- Conditions
- StumpPancreas NeoplasmSurgery--Complications
- Interventions
- Procedure: staple onlyProcedure: reinforcement of the staple line
- First Posted Date
- 2020-12-11
- Last Posted Date
- 2021-02-12
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 124
- Registration Number
- NCT04663789
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- Early Breast Cancer
- Interventions
- Drug: Nab-paclitaxel in combination with pyrotinib
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2020-12-09
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 261
- Registration Number
- NCT04659499
© Copyright 2025. All Rights Reserved by MedPath